Benign Prostatic Hyperplasia
370
46
60
194
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
61 trials with published results (16%)
Research Maturity
194 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
24 terminated out of 370 trials
89.0%
+2.4% vs benchmark
24%
89 trials in Phase 3/4
31%
61 of 194 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 194 completed trials
Clinical Trials (370)
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH
Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)
Ambulatory Long Length URodynamics Evaluation
Modified SOLTIVE Study
Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
VR Discharge Education After TURP
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
Ejaculation-Preserving Versus Conventional Dual Wavelength Diode Laser Vaporization of the Prostate
Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH)
BPH Global Registry
Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia
Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization